Fidelity International has shortened the subscription period of a Chinese onshore bond fund after hitting the sales target in less than two weeks, reflecting avid investor interest in China's surging ...
Tevogen Bio develops T-cell therapies for infectious diseases, cancers, and neurological disorders. Read why I've initiated a small position in TVGN stock.